Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients

Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients

Abstract Aims Both S100A4 and Glypican-3 have been known to be engaged in HCC development and progression. This study aimed to evaluate both S100A4 and GPC3 expression in HCC tissues as a prognostic markers. Methods Tissues from 70 patients of HCC in cirrhotic HCV patients were evaluated by immunohi...

Full description

Bibliographic Details
Main Authors: Mahmoud El-Bendary, Khaled Farid, Mohammad Arafa, Wagdi Elkashef, Talaat Abdullah, Ahmed El-Mesery
Format: Article
Language:English
Published: SpringerOpen 2023-08-01
Series:Journal of the Egyptian National Cancer Institute
Subjects:
Hepatocellular carcinoma
Cirrhotic
HCV
Prognosis, S100A4
Glypican-3
Online Access:https://doi.org/10.1186/s43046-023-00184-1

Internet

https://doi.org/10.1186/s43046-023-00184-1

Similar Items